UPDATE: Citi Upgrades Ultragenyx Pharma (RARE) to Buy
Tweet Send to a Friend
(Updated - May 6, 2021 5:06 AM EDT)
Citi analyst Yigal Nochomovitz upgraded Ultragenyx Pharma (NASDAQ: RARE) from Neutral ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Citi analyst Yigal Nochomovitz upgraded Ultragenyx Pharma (NASDAQ: RARE) from Neutral ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE